FdaApplication

NDA 021883

Back to search

Identifiers

Properties

PropertyValue
applicant_nameABBVIE INC
application_typeNDA
approval_date2014-05-23

Products (1)

ProductActive ingredientStrengthDosage form
DALVANCEDALBAVANCIN HYDROCHLORIDEEQ 500MG BASE/VIALPOWDER;INTRAVENOUS

1 product